CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 08, 2020 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, announced today that it will be providing its fully validated SARS-CoV-2-PCR tests to students from the Carolinum High School, the largest high school in Neustrelitz, Germany. In doing so, the Company hopes to spearhead a return to normalcy for students ─ creating a...
|